Advertisement

June 21, 2011

Medrad Launches 120-cm AngioJet Solent Omni Thrombectomy Catheter

June 22, 2011—Medrad Interventional (Indianola, PA) announced the launch of the Solent Omni, part of the company's Solent family of thrombectomy catheters that are designed for the treatment of large, difficult-to-remove thrombus in the peripheral vasculature. The Solent Omni's 120-cm length gives it a longer reach than the 90-cm Solent Proxi. The Solent catheters are enabled for power-pulse delivery, allowing them to power-infuse lytic into the thrombus.

According to Medrad, the Solent thrombectomy devices are available for use with the AngioJet Ultra system and provide the highest clot-removing power in the AngioJet range. They also allow for swapping of guidewires during the procedure. A port with a stopcock on the catheter's hub facilitates in situ contrast injection. A flexible, polymer-clad spiral shaft with a hydrophilic coating on the distal section provides improved handling. The Solent catheters are based on the AngioJet Cross-Stream technology, which uses high-speed saline jets inside the catheter tip to create a powerful, low-pressure zone that entrains and removes clot, the company stated.

Advertisement


June 28, 2011

Single-Center Outcomes of TEVAR Studied in a Variety of Pathologies

June 20, 2011

AHA Announces Data Showing Millions of PAD Patients Are Not Receiving Medical Therapy